These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease. Henry-Amar M. NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791 [Abstract] [Full Text] [Related]
10. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute. Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I. Neoplasma; 2000 Jun; 47(2):129-32. PubMed ID: 10985481 [Abstract] [Full Text] [Related]
11. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. Blayney DW, Longo DL, Young RC, Greene MH, Hubbard SM, Postal MG, Duffey PL, DeVita VT. N Engl J Med; 1987 Mar 19; 316(12):710-4. PubMed ID: 3821809 [Abstract] [Full Text] [Related]
12. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ. Ai Zheng; 2007 Dec 19; 26(12):1360-4. PubMed ID: 18076802 [Abstract] [Full Text] [Related]
16. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A. J Clin Oncol; 2007 May 20; 25(15):2000-5. PubMed ID: 17420510 [Abstract] [Full Text] [Related]